News & Articles

Initiative to expand testing access to underserved U.S. communities

As the FDA and NIH plan to phase out animal-based drug testing, organ-chip models are filling this critical gap

'Scripting Possibilities' to power the future of biotechnology

Revvity’s Euroimmun shares insights on the role of amyloid-beta, tau, and neurofilament in Alzheimer’s disease diagnostics

Secure your ticket to visit the biggest lab industry trade show in the UK

The launch marks the highlight of a 10-year journey

A focused clinical approach to second-generation anti-seizure medications and laboratory diagnostics

Cleanroom microbiology expert, Cherwell, to become AnalytiChem UK Ltd from 1st September 2025

Understaffing in the lab threatens the collaboration doctors depend on

Researchers receive funding to explore how fluorescent materials can detect the presence of pesticides and herbicides in food production

AliveDx has received IVDR-CE Mark for its multiplexed MosaiQ AiPlex Vasculitis (VAS) assay, designed to speed diagnosis of ANCA-associated vasculitides and Anti-GBM (Goodpasture’s) disease

Direct, high-resolution imaging of cells on membrane inserts without removal or disruption

Dr. Michael Kiebish of BPGbio shares insight into its AI-powered NAi Interrogative Biology Platform and discusses the growing importance of multiomic data

Enhance sample traceability, streamline inventory, and support compliance with a trusted, user-friendly LIMS solution

46 companies and organizations were honored for supporting the association through advertising, sponsorships, and exhibits

Join experts as they discuss the significant hurdles in spatial proteomics and how innovative tools such as the EVOS S1000 Spatial Imaging System are set to redefine research capabilities in this rapidly evolving field

First-of-its-kind study at ADLM 2025 lays the foundation for addressing public health threat

From concept to clinic, NExT gives researchers and developers access to Fujirebio’s unmatched expertise in neurological biomarker testing

Crown Bioscience’s in vitro model offers a physiologically relevant tool to evaluate drug efficacy for hematological diseases

The comprehensive preclinical screening platform was validated using HER2 x TROP2 bsADC as a proof of concept

New findings at ADLM 2025 could remedy this failure

Dr. Stanley F. Lo, DABCC, FADLM, has been elected to serve on the ADLM board of directors as president-elect starting in August 2025

Discover how Waters' HRMS innovations are enhancing the accuracy and scope of PFAS detection and analysis

The award recognises Gradientech’s impactful and innovative campaign to raise awareness about its QuickMIC ultra-rapid antibiotic susceptibility testing (AST) system